Post PCI care and patient quality of life of octogenarians compared with non-octogenarians in the Thai PCI registry (n=22 741)
| Post PCI care and patient quality of life | Octogenarian (age ≥80) | Non-octogenarian (age 18–79) | P value |
| N (%) | N (%) | ||
| Antiplatelet therapy | |||
| Aspirin | 1876 (94.1) | 19 880 (97.8) | <0.001 |
| Clopidogrel | 1659 (83.2) | 16 204 (79.7) | <0.001 |
| Ticagrelor | 203 (10.2) | 2980 (14.7) | <0.001 |
| Prasugrel | 21 (1.1) | 615 (3.0) | <0.001 |
| Vitamin K antagonist | 64 (3.2) | 476 (2.3) | 0.016 |
| NOAC | 38 (1.9) | 165 (0.8) | <0.001 |
| Statin | 1781 (89.4) | 18 979 (93.3) | <0.001 |
| Beta blocker | 1088 (54.6) | 12 569 (61.8) | <0.001 |
| ACEI or ARBs | 813 (40.8) | 10 299 (50.7) | <0.001 |
| Cardiac rehabilitation referral | 670 (31.9) | 7858 (43.6) | <0.001 |
| Patient quality of life | |||
| EQ-5D before PCI, mean (SD) | 61.8 (19.0) | 67.0 (19.3) | <0.001 |
| EQ-5D after PCI, before discharge, mean (SD) | 77.5 (14.6) | 82.6 (17.7) | <0.001 |
ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; EQ-5D, European Quality of Life 5 Dimensions score; NOAC, novel oral anticoagulant; PCI, percutaneous coronary intervention.